Back to search
Central Line-associated Bloodstream Infections
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Central Line-associated Bloodstream Infections trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Central Line-associated Bloodstream Infections trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase 3, randomized, double-blind, controlled, adaptive, 2-arm, multicenter study to demonstrate the efficacy and safety of DefenCath in adult partici…
Central line-associated bloodstream infections (CLABSIs) are the most common healthcare-associated infection in children and are associated with morbidity and m…
In the intensive care unit, patients' care and secure drugs administration require a central venous catheter. These invasive devices can lead to complications,…
In recent years, with the rapid advancement of medical technology and the rapid development of critical care medicine, the use of various central venous cathete…
The goal of this type of study is to construct the continuous quality promotion project "ICU-NO CRBSI(Catheter-Related Bloodstream Infection , CRBSI)" based on…
The management of premature infants hospitalized in neonatal units requires the simultaneous intravenous (IV) infusion of several drugs and parenteral nutrition…
The EAP for DefenCath is designed to provide access to a broader population of adult and pediatric patients using catheters for various serious medical conditio…
The IVCare trial is a multicentre adaptive platform study evaluating interventions to prevent infections and other complications associated with central venous…